Aphria is one of the biggest names on the cannabis stock market right now. Before we get into numbers, let’s get familiar with the company itself. The company was founded on June 22, 2011 by Cole Cacciavillani and John Cervini. Its headquarters is located in Leamington, Canada. They sell their products locally, as well as internationally (North America, Europe, Latin America, Caribbean, Africa and Oceania. ), they also offer online products. Aphria is proud to be fully eco-friendly or as they like to call themselves “powered by sunlight”. Their main focus is to produce product that is grown under the most natural conditions available to deliver the safest medical marijuana products. The plant is grown in their state-of-art greenhouse. They are known for their consistency and quality. They not only handle the production of the product, but supply as well. They produce sativa, indica, hybrid marijuana products and cannabis oils. Some of Aphria’s most popular products include cannabis capsules, oral solutions, concentrate syringes and tetrahydrocannabinol and cannabidiol vaporizers.
If you are looking into pot stocks and thinking of investing, then you need to do a thorough research on the company and evaluate its current state as well as future. Aphria is definitely one of the smartest and safest choices, when it comes to buying marijuana stocks. This is pretty clear after looking into their history.
Aphria is the first public licensed medical cannabis producer to show positive earnings from operations. It is also the first to report positive cash flow in consecutive quarters.
Aphria’s transfer agent is Computershare Trust Company of Canada.
Aphria Inc.’s ISS Governance Quality Score as of January 1, 2019 is 7. Corporate governance scores courtesy of Institutional Shareholder Services (ISS).
There has been a lot going on around Aphria with its key leadership stepping down; however, the numbers haven’t been affected by this fact. On the opposite, they have actually gone up. And it is highly probable that the number will keep going up. The reason behind this is pretty simple. Aphria is dependable. They have enough products to supply the market. Let’s have a look at their farms.
Aphria One – Leamington, Ontario, Canada – 87 acres. The farm has 300,000 square feet of production space capable of producing 30,000 kg annually. The company is also planning expansions that will add up to a combined total of more than 1,000,000 square feet of high-tech greenhouse amenities producing 110,000 kg yearly.
Aphria Diamond – Leamington, Ontario, Canada – 100 acres. Aphria owns 51% of its subsidiary. Right now, it is undergoing a retrofit and is anticipated to start work on 1,400,000 square feet of superior greenhouse production in early 2019. The predicted production rate is 140,000 kg annually.
Broken Coast Cannabis – Duncan, British Columbia, Canada – annual production rate of 5,000 kg.
ARA Avanti RX – Brampton, Ontario, Canada – Aphria’s subsidiary
Colcanna SAS – Chinchiná, Caldas, Colombia – 34 acres.
Aphria’s 90% owned subsidiary with production rate of 30,000 kg.
ABP, S.A. – Buenos Aires, Argentina – Aphria’s subsidiary
Marigold Projects Jamaica Limited – Kingston, Jamaica – 49% owned subsidiary
Aphria Germany – Hamburg, Germany
ASG Pharma Ltd. – Valleta, Malta
FL-Group – Vado LIgure, Italy
Strategic Partnership with Schroll Medical – Arslev, Denmark
CannInvest Africa Ltd. – South Africa & Lesotho
Althea – Melbourne, Australia
To give you a better idea, let’s convert KGs to $$. Only at Aphria One there are about 300 plants. On average, one plant can produce 453 grams of flower; wholesale price for 1 gram is about $5.20. Do some quick math and you will get the plants worth of about $706,680.00 USD. The flowering stage takes about 4 to 6 months. So, you can profit 2-3 times per year, adding up to $1.5 - $2 million in revenue per year. And all this, from one farm alone.
If you are still not convinced, here are Aphria s Q2 2019 Earnings And Revenue Report from the Seeking Alpha News Feed:
Aphria shares cannot be purchased directly from the company. They are available for sale on the open market through a broker or an online trading platform. Aphria trades under APHA on Toronto Stock Exchange (TSX) in Canada and APHA on New York Stock Exchange (NYSE) in the United States of America. The company’s current share price can be found on TMX Money or on their website.
Aphria has been on the market for 8 years now and it continues its gradual growth. With worldwide connections, quality product and state-of-art technology, investing in Aphria stocks is definitely an opportunity one should not miss out on.